12/06/2025
These recommendations from the NDIA are incredibly disappointing. Allied Health professionals and NDIS participants deserve better. It’s not good enough.
The NDIA has released its Annual Pricing Review, and once again, there is no increase in price limits for speech pathology therapy for 2025-26. This marks the sixth consecutive year of frozen prices, despite rising costs and clear advice from Speech Pathology Australia regarding risk of market failure.
We know this outcome is deeply disappointing for members. It raises serious concerns for the sustainability of speech pathology services under the NDIS and participant access to vital care.
Speech Pathology Australia is:
> Advocating directly to the NDIA and government
> Calling for CPI-linked annual price indexation
> Engaging directly with the NDIA’s pricing review team
> Pushing for pricing to be determined by an independent authority
> Advocating for increased therapy price limits, and funding for supervision and training and group therapy.
We remain committed to fighting for fair, sustainable pricing for our profession.
👉 https://bit.ly/4jO3C4e